Abstract
P19 embryonal carcinoma cells are known to differentiate into neurons and glia when treated with relatively high concentrations (>100 nM) of retinoic acid (RA). Concomitant with this RA-induced neural differentiation, we observed an activation of the c-Jun amino-terminal kinase (JNK). JNK was required for the RA-induced neural differentiation, because dominant-negative JNK blocked the differentiation. Studies using protein phosphatase inhibitors and protein kinase inhibitors suggested that both okadaic acid-sensitive protein phosphatase(s) and protein kinase C participate in the RA-induced activation of JNK.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carcinoma, Embryonal / enzymology
-
Carcinoma, Embryonal / pathology*
-
Cell Differentiation / drug effects*
-
Enzyme Activation
-
Enzyme Inhibitors / pharmacology
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases / metabolism*
-
Neurons / cytology
-
Phosphoprotein Phosphatases / antagonists & inhibitors
-
Phosphorylation
-
Protein Kinase C / antagonists & inhibitors
-
Tretinoin / pharmacology*
-
Tumor Cells, Cultured
Substances
-
Enzyme Inhibitors
-
Tretinoin
-
Protein Kinase C
-
JNK Mitogen-Activated Protein Kinases
-
Mitogen-Activated Protein Kinases
-
Phosphoprotein Phosphatases